ResearcherCurtin UniversityActive in the last 2 years
Ilaria Casari
Matched on ORCID iD 0000-0003-2869-8810; OpenAlex author ID A5035404635. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 11
- Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer progression. Co-author DOI 10.1016/j.cellsig.2025.111775↗
- Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota. Co-author DOI 10.3390/ijms26167733↗
- Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models. Co-author DOI 10.3390/ijms25042340↗
- Can the molecules carried by extracellular vesicles help to diagnose pancreatic cancer early? First author DOI 10.1016/j.bbagen.2023.130387↗
- Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine. Co-author DOI 10.1016/j.jbior.2021.100857↗
- Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance. Co-author DOI 10.3390/cancers14235793↗
- Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2020.12.005↗
- Exosomal integrins and their influence on pancreatic cancer progression and metastasis. Co-author DOI 10.1016/j.canlet.2021.03.010↗
- Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation. Co-author DOI 10.3390/cancers11111695↗
- Pancreatic cancer: Current research and future directions. Last author DOI 10.1016/j.bbcan.2016.01.001↗
- Diet and Pancreatic Cancer Prevention. Co-author DOI 10.3390/cancers7040892↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco Falasca · 11 shared papers, 2015–2025 · strength 2.15
- Paper Can the molecules carried by extracellular vesicles help to diagnose pancreatic cancer early? DOI 10.1016/j.bbagen.2023.130387↗
- Paper Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models. DOI 10.3390/ijms25042340↗
- Paper Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer pro… DOI 10.1016/j.cellsig.2025.111775↗
- Pratibha Malhotra · 3 shared papers, 2023–2025 · strength 0.80
- Paper Can the molecules carried by extracellular vesicles help to diagnose pancreatic cancer early? DOI 10.1016/j.bbagen.2023.130387↗
- Paper Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer pro… DOI 10.1016/j.cellsig.2025.111775↗
- Paper Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota. DOI 10.3390/ijms26167733↗
- Ranjith Palanisamy · 2 shared papers, 2024–2025 · strength 0.53
- Aikaterini Emmanouilidi · 2 shared papers, 2022–2025 · strength 0.47
- Paper Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer pro… DOI 10.1016/j.cellsig.2025.111775↗
- Paper Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine. DOI 10.1016/j.jbior.2021.100857↗
- Eunice Eugenia Robless · 2 shared papers, 2021 · strength 0.38
- Alice Domenichini · 2 shared papers, 2019–2022 · strength 0.33
- Marina Pajic · 1 shared paper, 2025 · strength 0.25
- Jordan Fyfe · 1 shared paper, 2025 · strength 0.25
- Arunima Panda · 1 shared paper, 2025 · strength 0.25
- Krish Ragunath · 1 shared paper, 2025 · strength 0.25
- Gitana María Aceto · 1 shared paper, 2022 · strength 0.16
- Federico Selvaggi · 1 shared paper, 2022 · strength 0.16
- Ingrid Garajová · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.